Workflow
行政处罚
icon
Search documents
四川南江交通建设投资有限公司因“未批先建”被罚款5万元
Qi Lu Wan Bao· 2025-12-18 02:39
近日,南江县交通运输局依法对四川南江交通建设投资有限公司作出行政处罚,因其在未取得合法开工手续的情况下,擅自组织实施道路工程建设,被 处以罚款人民币5万元整。该处罚决定已于2025年12月17日正式生效。 根据南江县交通运输局出具的行政处罚决定书(文号:川1904交罚〔2025〕61号)显示,2025年11月11日,该局执法人员刘育良、李晓菊接到违法线索 移送通知后,立即展开调查。经核实,四川南江交通建设投资有限公司在负责"粮油现代农业园区道路建设工程"时,未依法办理开工建设所需的前置审 批手续,便先行组织施工活动。该行为已构成"未经有关交通主管部门批准擅自进行公路建设项目施工"。 南江县交通运输局依据《中华人民共和国公路法》第七十五条的规定,并参照《四川省交通运输行政处罚裁量基准》,对四川南江交通建设投资有限公 司作出了上述罚款决定。该法律规定,违反本法规定,未经有关交通主管部门批准擅自施工的,交通主管部门可以责令停止施工,并可以处以罚款。 | 行政处罚详情 四川南江交通建设投资有限公司 | | --- | | 信用主体名称 四川南江交通建设投资有限公司 | | 统一社会信用代码 9151192209495 ...
600608、600079,突发
Zheng Quan Shi Bao· 2025-12-12 12:35
Group 1 - *ST Hu Ke announced on December 12, 2025, that it received a notice of investigation from the China Securities Regulatory Commission (CSRC) due to suspected violations of information disclosure laws [1][3] - The company stated that its production and operational activities are currently normal and that the investigation will not have a significant impact on its management [3] - The main business of *ST Hu Ke focuses on the trade of agricultural and chemical products, classified under "F51 Wholesale Industry" according to the CSRC [3] Group 2 - For the third quarter, *ST Hu Ke reported a revenue of 1.04 million yuan, a year-on-year decrease of 56.95%, with a net profit attributable to shareholders of 1.0271 million yuan [4] - As of December 12, 2025, *ST Hu Ke's stock price was 3.81 yuan per share, with a total market capitalization of 1.253 billion yuan [4] Group 3 - On the same day, Renfu Pharmaceutical announced it received a notice of administrative penalty from the CSRC for failing to disclose non-operating fund occupation and significant omissions in its annual reports for 2020 and 2022 [7] - Renfu Pharmaceutical's stock will be subject to risk warnings starting December 16, 2025, with a trading limit of 5% on price fluctuations [7][9] - The company, established in 1993, is a leading pharmaceutical enterprise in Hubei Province, focusing on a full industrial chain from intermediates to drug formulations [9] Group 4 - As of December 12, 2025, Renfu Pharmaceutical's stock price was 18.15 yuan per share, with a total market capitalization of 29.625 billion yuan [9]
沈阳化工股份有限公司关于独立董事辞职的公告
Group 1 - The resignation of independent director Yang Xianghong will result in the number of independent directors being less than one-third of the board members, which does not comply with relevant regulations [2][4] - Yang Xianghong's resignation will take effect after the election of a new independent director at the shareholders' meeting, but he will continue to fulfill his duties until then [2][4] - The board expresses gratitude for Yang Xianghong's contributions during his tenure [2] Group 2 - Shenyang Chemical Co., Ltd. received an administrative penalty notice from the China Securities Regulatory Commission (CSRC) on September 30, 2025, leading to the implementation of risk warnings on its stock [4][5] - The risk warning was due to false disclosures in the financial indicators from 2018 to 2021, but it does not meet the criteria for mandatory delisting [5][6] - The company has taken corrective actions, including self-examination and adjustments in its financial reports, which were disclosed in the 2023 annual report [6][7] Group 3 - The company has implemented measures to ensure compliance with laws and regulations, including enhancing internal governance and audit processes [8] - The company plans to apply for the removal of the risk warning once it meets the necessary conditions set by the Shenzhen Stock Exchange [8] - As of the announcement date, the company's production and operational activities are normal, and it has maintained stable financing [8]
停止运营!创始人已退出,此前被指大规模裁员
中国基金报· 2025-11-22 14:11
近日,北京市东城区 市场监督管理局公布的 一则行政处罚告知书显示 北京叶合拍卖有限公司 工作人员涉嫌以竞买人的身份 参与自己组织的拍卖活动一案 已调查终结 来源:中国经济网微信综合新闻坊、澎湃新闻 告知书显示,北京叶合拍卖有限公司(原名北京小观拍卖有限公司)已于2024年7月停止网 络拍卖业务, "观复"客户端因无力支付费用停止运营 。该公司因工作人员在2024年5月两次 以竞买人身份参与自己组织的拍卖活动,涉嫌违反《拍卖法》,被处以警告。监管部门认定其 违法情节轻微、成交金额较低,故从轻处罚。 工商信息表明, 马未都及其子马天,已于2024年退出观复文化及关联公司股权 ,公司更名 为北京叶泰文化有限公司(后改为叶合),由尹帆、陈业接手。 另据报道,观复文化此前曾被指 有80余名员工被单方面解约,而该公司共有员工86人。 对 此, 马未都回应称,观复文化旗下3家公司共有91人,目前51人正常在职,38人离职给予了 满意的补偿,另有2人因为诉讼尚在处理中,会尊重并执行法律的裁判结果。 据了解,目前,美团、携程、大众点评等消费平台均可正常购买观复博物馆北京、上海两馆的 门票。 北京市东城区市场监督管理局在行政处罚 ...
五洲新春:向特定对象发行股票,子公司行政处罚不属重大违法
Xin Lang Cai Jing· 2025-11-17 08:51
Core Viewpoint - The company is preparing to issue A-shares to specific targets for the year 2025, and has received a supplementary legal opinion from Guohao Law Firm regarding the Shanghai Stock Exchange's inquiry letter [1] Regulatory Compliance - The company and its subsidiaries, including Sichuan Wuzhou Changxin Technology and Zhejiang Xinlong Industry, have faced a total of 6 administrative penalties during the reporting period, related to unauthorized land occupation and fire safety violations [1] - The fines imposed range from 4,039.80 yuan to 1.675 million yuan, with most penalties being at the lower end of the regulatory range [1] Impact Assessment - The penalties have not resulted in serious environmental pollution, major casualties, or adverse social impacts, indicating that the violations are not classified as significant harm to investors' legal rights or public interests [1]
向证监局报虚假资料!监管出手,撤销业务资格!
Core Viewpoint - The China Securities Regulatory Commission (CSRC) has imposed administrative penalties on Beijing Zhongfang Xinfeng Investment Management Consulting Co., Ltd. (Zhongfang Xinfeng) for serious violations, including failure to maintain required documentation and submitting false reports to regulatory authorities [1][5][8]. Summary by Sections Violations and Penalties - Zhongfang Xinfeng failed to properly maintain marketing service records for 13 clients from 2021 to 2023 and did not retain complete records for 221 clients in 2020 [4]. - The CSRC found that Zhongfang Xinfeng submitted false statements regarding client additions during a suspension period, claiming no new clients while actually adding 223 [5][6]. - The company was fined 3 million yuan and had its securities investment consulting business license revoked due to these violations [8]. Management Accountability - Zhang Song, the chairman of Zhongfang Xinfeng, was held responsible for the company's violations and received a warning along with a fine of 600,000 yuan [8]. - The CSRC determined that Zhang Song played a significant role in the company's major illegal activities, leading to a 6-year ban from the securities market [8]. Regulatory Process - The CSRC conducted a thorough investigation and held a hearing to consider Zhongfang Xinfeng's defense, which was ultimately rejected due to insufficient evidence [6][7].
东尼电子因年报披露存在虚假记载等被罚700万元,公司股票将被实施其他风险警示
Core Viewpoint - Dongni Electronics has received an administrative penalty notice from the Zhejiang Regulatory Bureau of the China Securities Regulatory Commission, leading to risk warnings for its stock due to violations including delayed disclosure of significant contract progress and false records in financial reports [1][2] Group 1: Administrative Penalties - The company is facing a warning and a fine of 7 million yuan for the violations identified [1] - The former chairman, Shen Xinfang, is subject to a warning and a fine of 3.5 million yuan [1] - The former general manager, Shen Xiaoyu, will receive a warning and a fine of 1.7 million yuan [1] - The former financial director, Yang Yun, is also warned and fined 1 million yuan [1] - Additional fines include 1 million yuan for former financial director Zhong Weiqin, 900,000 yuan for former board secretary Weng Xinyi, and 600,000 yuan for former deputy general manager and board secretary Luo Binbin [1] Group 2: Stock Trading Regulations - According to the revised Shanghai Stock Exchange listing rules, the company's stock will be suspended for one day on October 30, 2025, and will be subject to risk warnings starting October 31, 2025 [2] - After the implementation of risk warnings, the stock will trade on the risk warning board with a daily price fluctuation limit of 5% [2]
因违法违规行为,金城医药董事长拟被罚150万元、禁入市场4年
Qi Lu Wan Bao· 2025-10-10 04:32
Core Viewpoint - Jin Cheng Pharmaceutical (300233.SZ) announced on October 9 that its actual controller and chairman, Zhao Yeqing, received a notice from the China Securities Regulatory Commission (CSRC) regarding allegations of market manipulation, as indicated in the administrative penalty notice [1][3]. Group 1: Allegations and Penalties - Zhao Yeqing, Wang Zhen, and Liu Feng are accused of violating Article 77 of the Securities Law of 2005, constituting market manipulation as per Article 203 of the same law [3]. - The proposed penalties include a total fine of 3 million yuan, with Zhao Yeqing responsible for 1.5 million yuan, Wang Zhen for 1.2 million yuan, and Liu Feng for 300,000 yuan [3]. - Zhao Yeqing will face a 4-year market ban, while Wang Zhen will be banned for 3 years, preventing them from engaging in securities business or holding positions in any public companies during the ban period [3]. Group 2: Previous Penalties - On March 12, 2025, Zhao Yeqing received a prior notice proposing the confiscation of illegal gains amounting to approximately 15.4391 million yuan, with Zhao Yeqing's share being 7.7196 million yuan [4]. - The previous proposed penalties included fines totaling approximately 46.3174 million yuan, with Zhao Yeqing liable for 23.1587 million yuan [4]. - The current proposed penalties are significantly lower than the previous ones, indicating a potential change in the regulatory approach or the circumstances surrounding the case [4]. Group 3: Company Overview - Jin Cheng Pharmaceutical was established in 2011 and is listed on the Shenzhen Stock Exchange's Growth Enterprise Market, employing over 3,900 people and operating more than 30 subsidiaries globally [8]. - The company specializes in the research, production, and sales of pharmaceutical intermediates, active pharmaceutical ingredients, drug formulations, and health products, and is recognized for its production of cephalosporin intermediates and other pharmaceutical products [8]. - Jin Cheng Pharmaceutical is a well-known manufacturer of anti-infection and women's health medications, with a comprehensive product line in the lifecycle of women's health [8].
先惠技术违反海关监管规定被行政处罚
Qi Lu Wan Bao· 2025-09-29 00:27
Core Viewpoint - Shanghai Xianhui Automation Technology Co., Ltd. has been penalized by the Shanghai Pudong International Airport Customs for violating customs regulations, resulting in a fine of RMB 31,000 due to discrepancies in the declared import goods [1][6]. Group 1: Company Information - Shanghai Xianhui Automation Technology Co., Ltd. was established in 2007 and went public on the Shanghai Stock Exchange's Sci-Tech Innovation Board in 2020, with stock code 688155 [10]. - In 2021, the company was included in the Ministry of Industry and Information Technology's list of the third batch of national-level specialized and innovative "little giant" enterprises [10]. Group 2: Customs Violation Details - The company, through Shanghai Shunwang International Freight Forwarding Co., Ltd., declared an import of a battery management system on March 28, 2025, with a total declared value of CIF $124,644.55 [1][4]. - Customs inspection revealed that the imported goods did not match the declaration, leading to a penalty [1][6]. - The assessed tax amount was RMB 67,492.29, with the total value of the goods determined to be RMB 893,763.75 [4][6].
美晨科技因财务造假,收《行政处罚事先告知书》
Ju Chao Zi Xun· 2025-09-27 09:48
Group 1 - Shandong Meichen Technology Co., Ltd. received an administrative penalty notice from the Shandong Securities Regulatory Bureau regarding information disclosure violations from 2014 to 2018 [2][3] - The company inflated revenue by a total of 1.44 billion yuan and profits by approximately 658 million yuan during the specified period through various fraudulent activities [3] - The inflated revenue and profit figures represented significant percentages of the disclosed profits for the respective years, with some years showing inflated profits accounting for over 75% of the total disclosed profits [3][4] Group 2 - The Shandong Securities Regulatory Bureau identified several responsible individuals, including the former chairman of Saishi Garden and the chairman of Meichen Technology, for failing to ensure the accuracy and completeness of the annual reports [4] - The proposed penalties include a warning and a fine of 600,000 yuan for Meichen Technology, with more severe penalties for individual responsible parties, including a 10-year market ban for the former chairman of Saishi Garden [4] - Following the notice, Meichen Technology announced that its stock would be subject to additional risk warnings and would change its trading name to "ST Meichen" starting September 30, 2025 [5] Group 3 - Meichen Technology specializes in non-tire rubber products and landscaping, having over 20 years of experience in the research and production of commercial vehicle damping rubber products [6] - The company has established itself as one of the largest suppliers in the domestic commercial vehicle damping rubber product sector, with a strong market share and technical advantages [6] - Meichen Technology has developed a comprehensive product lifecycle development system and has become a leading supplier in the suspension system product field, showcasing its technological capabilities and competitive pricing [6]